Medicxi Ventures Management (Jersey) Ltd Long-Term Concentrated

CIK: 0001715579 · Show all filings

Period: Q3 2020 (← Previous) (Next →)

Filing Date: Oct 27, 2020

Total Value ($000): $209,408 (100.0% shares, 0.0% debt)

Holdings (5)

PCVX VAXCYTE INC 44.5%

Value ($000) $93,203 Shares 1,887,478 Est. Cost $32.16 Unrealized +23.8%

PHAT PHATHOM PHARMACEUTICALS INC 36.2%

Value ($000) $75,828 Shares 2,067,861 Est. Cost $25.13 Unrealized +37.8%

— MERUS N V 9.2%

Value ($000) $19,200 Shares 1,600,000 Est. Cost $14.08 Unrealized —

— CHECKMATE PHARMACEUTICALS IN 8.3%

Value ($000) $17,284 Shares 1,501,716 Est. Cost $11.51 Unrealized —

— OBSEVA SA 1.9%

Value ($000) $3,893 Shares 1,570,000 Est. Cost $3.82 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
PCVX	VAXCYTE INC	1,887,478	$93,203	44.5%	$32.16	+23.8%	COM	92243G108
PHAT	PHATHOM PHARMACEUTICALS INC	2,067,861	$75,828	36.2%	$25.13	+37.8%	COM	71722W107
—	MERUS N V	1,600,000	$19,200	9.2%	$14.08	—	COM	N5749R100
—	CHECKMATE PHARMACEUTICALS IN	1,501,716	$17,284	8.3%	$11.51	—	COM	162818108
—	OBSEVA SA	1,570,000	$3,893	1.9%	$3.82	—	COM	H5861P103